IBM Watson's Oncology Expert Advisor received a $62 million investment over five years, but an internal investigation by the University of Texas M. D. Anderson Cancer Center found it fell short of the medical 'gold standard.'
Notes on verification
Corroborated by independent, high-quality journalism (STAT News investigation and Forbes reporting) citing internal University of Texas MD Anderson audit documents; figures and outcome are consistent across sources. [tier=silver indep_score=0.825 clusters=2 claim_tier=notable]